Cargando…
Evaluating barriers to and promotors of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs (Commentary)()
Autor principal: | Ranganathan, Sarath C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419212/ https://www.ncbi.nlm.nih.gov/pubmed/34503930 http://dx.doi.org/10.1016/j.jcf.2021.08.026 |
Ejemplares similares
-
Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs()
por: Gifford, Alex H., et al.
Publicado: (2021) -
TeleHealth or TeleWealth? Equity challenges for the future of cystic fibrosis care (Commentary)()
por: Franciosi, Alessandro N, et al.
Publicado: (2021) -
Rising to the challenges of the pandemic: Telehealth innovations in U.S. emergency departments
por: Uscher-Pines, Lori, et al.
Publicado: (2021) -
P24 Telehealth Access and Use by the U.S. Medicare Population during the Pandemic
por: Swenson, T
Publicado: (2022) -
Ivacaftor, not ivacaftor/lumacaftor, associated with lower pulmonary inflammation in preschool cystic fibrosis
por: Shanthikumar, Shivanthan, et al.
Publicado: (2022)